Fromkin Andrew J. bought IMVT
May 28, 2026 · Form 4 insider transaction
Fromkin Andrew J. bought 16,260 shares of Immunovant, Inc. at $14.70 per share, a transaction worth $239.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
16,260
Price
$14.70
Total value
$239.0K
InsiderFromkin Andrew J.
Role—
CompanyImmunovant, Inc. (IMVT)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 28, 2026
Filing dateMay 29, 2026
Shares owned after296,333
OwnershipDirect
10b5-1 planNo
AmendedNo